BLFS – the most advanced company for biopreservation media products!
Zacks small-cap research - Demand for biopreservation media is estimated to grow at an
annual rate of almost 20% over the next several years,
largely driven by rapid growth of the emerging field of
regenerative medicine (including cell therapy and tissue
engineering, according to MedMarket Diligence). Another study, from Visiongain, also supports a robust outlook for regenerative medicine and predicts this market
will grow from $1.4 billion in 2012 to $10 billion in 2020 (~28% CAGR).
BioLife expects to benefit from the emerging field of regenerative medicine and is positioning their HypoThermosol and CryoStor products as a better
alternative to other branded biopreservation media and home-brews, the latter which are estimated to hold as
much as 80% of the regenerative medicine market.